US Stock MarketDetailed Quotes

CNTX Context Therapeutics

Watchlist
  • 1.5000
  • -0.1300-7.98%
Close Nov 21 16:00 ET
  • 1.4000
  • -0.1000-6.67%
Pre 08:07 ET
112.50MMarket Cap-1704P/E (TTM)

Context Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
202.59%18.7M
-41.64%3.09M
-42.65%3.82M
68.49%25.07M
78.58%6.93M
52.68%6.18M
50.87%5.29M
93.63%6.67M
100.07%14.88M
25.56%3.88M
Selling and administrative expenses
10.67%1.88M
-6.96%1.7M
-13.21%1.85M
-6.42%7.29M
-6.11%1.63M
-13.97%1.7M
-7.99%1.83M
1.93%2.13M
114.43%7.79M
-3.38%1.74M
-General and administrative expense
10.67%1.88M
-6.96%1.7M
-13.21%1.85M
-6.42%7.29M
-6.11%1.63M
-13.97%1.7M
-7.99%1.83M
1.93%2.13M
114.43%7.79M
-3.38%1.74M
Research and development costs
275.13%16.83M
-59.99%1.38M
-56.49%1.97M
150.77%17.78M
147.19%5.3M
115.89%4.49M
128.11%3.46M
235.53%4.53M
86.36%7.09M
65.80%2.14M
Operating profit
-202.59%-18.7M
41.64%-3.09M
42.65%-3.82M
-68.49%-25.07M
-78.58%-6.93M
-52.68%-6.18M
-50.87%-5.29M
-93.63%-6.67M
-100.07%-14.88M
-25.56%-3.88M
Net non-operating interest income expense
328.21%1.24M
186.47%840.15K
-57.15%152.35K
112.69%1.16M
-31.46%224.72K
51.08%290.44K
1,277.13%293.27K
5,963.13%355.54K
951.91%547.27K
103,983.49%327.86K
Non-operating interest income
328.21%1.24M
186.47%840.15K
-57.15%152.35K
112.69%1.16M
-31.46%224.72K
51.08%290.44K
1,277.13%293.27K
5,963.13%355.54K
--547.27K
--327.86K
Other net income (expense)
-114.00%-2.15K
50.05%-6.11K
24.74%3.35K
88.93%-55.57K
-2,568.41%-61.4K
903.20%15.37K
97.55%-12.23K
316.95%2.69K
83.01%-502K
-733.70%-2.3K
Special income (charges)
----
----
----
--0
----
----
----
----
83.81%-500K
--0
-Less:Other special charges
----
----
----
----
----
----
----
----
-83.81%500K
--0
Other non- operating income (expenses)
-114.00%-2.15K
50.05%-6.11K
24.74%3.35K
-2,672.95%-55.57K
-2,568.41%-61.4K
903.20%15.37K
-305,775.00%-12.23K
316.95%2.69K
-101.62%-2K
-733.70%-2.3K
Income before tax
-197.21%-17.46M
55.01%-2.25M
41.86%-3.67M
-61.53%-23.96M
-90.34%-6.77M
-52.42%-5.87M
-25.71%-5.01M
-83.47%-6.31M
-41.88%-14.84M
-15.04%-3.56M
Income tax
Net income
-197.21%-17.46M
55.01%-2.25M
41.86%-3.67M
-61.53%-23.96M
-90.34%-6.77M
-52.42%-5.87M
-25.71%-5.01M
-83.47%-6.31M
-41.88%-14.84M
-15.04%-3.56M
Net income continuous Operations
-197.21%-17.46M
55.01%-2.25M
41.86%-3.67M
-61.53%-23.96M
-90.34%-6.77M
-52.42%-5.87M
-25.71%-5.01M
-83.47%-6.31M
-41.88%-14.84M
-15.04%-3.56M
Minority interest income
Net income attributable to the parent company
-197.21%-17.46M
55.01%-2.25M
41.86%-3.67M
-61.53%-23.96M
-90.34%-6.77M
-52.42%-5.87M
-25.71%-5.01M
-83.47%-6.31M
-41.88%-14.84M
-15.04%-3.56M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-197.21%-17.46M
55.01%-2.25M
41.86%-3.67M
-61.53%-23.96M
-90.34%-6.77M
-52.42%-5.87M
-25.71%-5.01M
-83.47%-6.31M
-41.88%-14.84M
-15.04%-3.56M
Basic earnings per share
40.54%-0.22
87.10%-0.04
42.50%-0.23
-61.29%-1.5
-90.91%-0.42
-54.17%-0.37
-24.00%-0.31
-81.82%-0.4
74.80%-0.93
-13.61%-0.22
Diluted earnings per share
40.54%-0.22
87.10%-0.04
42.50%-0.23
-61.29%-1.5
-90.91%-0.42
-54.17%-0.37
-24.00%-0.31
-81.82%-0.4
74.80%-0.93
-13.61%-0.22
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 202.59%18.7M-41.64%3.09M-42.65%3.82M68.49%25.07M78.58%6.93M52.68%6.18M50.87%5.29M93.63%6.67M100.07%14.88M25.56%3.88M
Selling and administrative expenses 10.67%1.88M-6.96%1.7M-13.21%1.85M-6.42%7.29M-6.11%1.63M-13.97%1.7M-7.99%1.83M1.93%2.13M114.43%7.79M-3.38%1.74M
-General and administrative expense 10.67%1.88M-6.96%1.7M-13.21%1.85M-6.42%7.29M-6.11%1.63M-13.97%1.7M-7.99%1.83M1.93%2.13M114.43%7.79M-3.38%1.74M
Research and development costs 275.13%16.83M-59.99%1.38M-56.49%1.97M150.77%17.78M147.19%5.3M115.89%4.49M128.11%3.46M235.53%4.53M86.36%7.09M65.80%2.14M
Operating profit -202.59%-18.7M41.64%-3.09M42.65%-3.82M-68.49%-25.07M-78.58%-6.93M-52.68%-6.18M-50.87%-5.29M-93.63%-6.67M-100.07%-14.88M-25.56%-3.88M
Net non-operating interest income expense 328.21%1.24M186.47%840.15K-57.15%152.35K112.69%1.16M-31.46%224.72K51.08%290.44K1,277.13%293.27K5,963.13%355.54K951.91%547.27K103,983.49%327.86K
Non-operating interest income 328.21%1.24M186.47%840.15K-57.15%152.35K112.69%1.16M-31.46%224.72K51.08%290.44K1,277.13%293.27K5,963.13%355.54K--547.27K--327.86K
Other net income (expense) -114.00%-2.15K50.05%-6.11K24.74%3.35K88.93%-55.57K-2,568.41%-61.4K903.20%15.37K97.55%-12.23K316.95%2.69K83.01%-502K-733.70%-2.3K
Special income (charges) --------------0----------------83.81%-500K--0
-Less:Other special charges ---------------------------------83.81%500K--0
Other non- operating income (expenses) -114.00%-2.15K50.05%-6.11K24.74%3.35K-2,672.95%-55.57K-2,568.41%-61.4K903.20%15.37K-305,775.00%-12.23K316.95%2.69K-101.62%-2K-733.70%-2.3K
Income before tax -197.21%-17.46M55.01%-2.25M41.86%-3.67M-61.53%-23.96M-90.34%-6.77M-52.42%-5.87M-25.71%-5.01M-83.47%-6.31M-41.88%-14.84M-15.04%-3.56M
Income tax
Net income -197.21%-17.46M55.01%-2.25M41.86%-3.67M-61.53%-23.96M-90.34%-6.77M-52.42%-5.87M-25.71%-5.01M-83.47%-6.31M-41.88%-14.84M-15.04%-3.56M
Net income continuous Operations -197.21%-17.46M55.01%-2.25M41.86%-3.67M-61.53%-23.96M-90.34%-6.77M-52.42%-5.87M-25.71%-5.01M-83.47%-6.31M-41.88%-14.84M-15.04%-3.56M
Minority interest income
Net income attributable to the parent company -197.21%-17.46M55.01%-2.25M41.86%-3.67M-61.53%-23.96M-90.34%-6.77M-52.42%-5.87M-25.71%-5.01M-83.47%-6.31M-41.88%-14.84M-15.04%-3.56M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -197.21%-17.46M55.01%-2.25M41.86%-3.67M-61.53%-23.96M-90.34%-6.77M-52.42%-5.87M-25.71%-5.01M-83.47%-6.31M-41.88%-14.84M-15.04%-3.56M
Basic earnings per share 40.54%-0.2287.10%-0.0442.50%-0.23-61.29%-1.5-90.91%-0.42-54.17%-0.37-24.00%-0.31-81.82%-0.474.80%-0.93-13.61%-0.22
Diluted earnings per share 40.54%-0.2287.10%-0.0442.50%-0.23-61.29%-1.5-90.91%-0.42-54.17%-0.37-24.00%-0.31-81.82%-0.474.80%-0.93-13.61%-0.22
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data